"Chondrocalcinosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.
| Descriptor ID |
D002805
|
| MeSH Number(s) |
C05.550.114.264 C05.550.354.125
|
| Concept/Terms |
Chondrocalcinosis- Chondrocalcinosis
- Chondrocalcinoses
- Pseudogout
- Calcium Pyrophosphate Deposition Disease
|
Below are MeSH descriptors whose meaning is more general than "Chondrocalcinosis".
Below are MeSH descriptors whose meaning is more specific than "Chondrocalcinosis".
This graph shows the total number of publications written about "Chondrocalcinosis" by people in this website by year, and whether "Chondrocalcinosis" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Chondrocalcinosis" by people in Profiles.
-
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152669.
-
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152670.
-
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction. Arthritis Care Res (Hoboken). 2022 10; 74(10):1649-1658.
-
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 08; 51(4):946-950.
-
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):655-660.
-
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):650-654.
-
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group. Semin Arthritis Rheum. 2020 08; 50(4):719-727.
-
Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans. Arthritis Care Res (Hoboken). 2017 09; 69(9):1400-1406.
-
Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study. J Clin Rheumatol. 2015 Jun; 21(4):189-92.
-
Is the double contour sign specific for gout? Or only for crystal arthritis? J Rheumatol. 2015 Mar; 42(3):353-4.